Litfulo 50 MG Oral Capsule

RxCUI: 2641607
RxNorm name: Litfulo 50 MG Oral Capsule
Display name: Litfulo 50 MG Oral Capsule
Full name: Litfulo 50 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Litfulo	RITLECITINIB	U.S. Pharmaceuticals	1882f799-61b0-4813-965a-4910c4ae419c	2026-06-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641607
Litfulo	RITLECITINIB	Pfizer Laboratories Div Pfizer Inc	6b2f9446-fb23-4741-b73a-5a2f993733c3	2026-06-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641607

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6b2f9446-fb23-4741-b73a-5a2f993733c3	Litfulo 50 MG Oral Capsule [PSN] · ritlecitinib 50 MG Oral Capsule [Litfulo] [SBD] · Litfulo 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule [SY]	3	5	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20260527
1882f799-61b0-4813-965a-4910c4ae419c	Litfulo 50 MG Oral Capsule [PSN] · ritlecitinib 50 MG Oral Capsule [Litfulo] [SBD] · Litfulo 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule [SY]	3	2	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20250320